Stock Information
Moderna Inc (MRNA)
Ticker Symbol: MRNA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $19,221.43 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -7.2617
Revenue (TTM): $4.96 M
Dividend Yield: N/A%
ROE: -30.15%
Latest News
-
Study Showing 50% Drop In COVID ER Visits Thanks To The Vaccine Put On Hold By CDC: Report
Fri, Apr 10, 2026 5:58 AM
-
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Thu, Apr 9, 2026 9:50 PM
-
3 Mid-Cap Stocks We’re Skeptical Of
Thu, Apr 9, 2026 1:57 PM
-
March Inflation Set For Biggest Jump Since June 2022 — When CPI Spikes, These Stocks Fall
Thu, Apr 9, 2026 1:24 PM
-
Moderna eyes international markets as growth driver, says Bank of America
Wed, Apr 8, 2026 4:58 PM
-
Moderna Flu And RSV Data Highlight Push Beyond COVID And Valuation Tension
Wed, Apr 8, 2026 4:14 PM
-
Moderna Is Most Shorted S&P 500 Stock Now. Is It a Contrarian Buy?
Wed, Apr 8, 2026 2:07 PM
-
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Wed, Apr 8, 2026 1:00 PM
-
MRNY: Strong Income Run Masks Rising Downside Risk
Wed, Apr 8, 2026 10:56 AM
-
Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas
Tue, Apr 7, 2026 4:01 PM
Key Financials
Financial data not available